drugset / Trial / NCT02924324
Local Injection of Pain Medication to Reduce Pain After Bone Marrow Procedures in Pediatric Neuroblastoma Patients
RandomizedCrossoverSingle-blindTreatment
Summary
The purpose of this study is to identify whether or not the addition of a numbing medicine that is injected directly into the site of the bone marrow procedure can reduce pain and the use of opioid pain medication after bone marrow procedures. The addition of this medicine, called ropivacaine, is the experimental part of this study. This is the first time ropivacaine will be directly injected into the bone marrow site at MSKCC Pediatrics.
Timeline
- Start
- 2016-10
- Primary completion
- 2019-11
- Completion
- 2019-11
Outcome
Missed primary endpoint
paper There was no significant difference in percentage of participants requiring opioids with GA versus GA + LA (24% vs 20%, P = .5). PMID 31366683 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ropivacaine | Other / unclassified | — | Other |